# SwishX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/swishx

- Industry: Software
- Headquarters: Los Altos, US
- Website: www.swishx.com
- Total disclosed funding: $2.2M
- Latest round: Seed (May 12, 2026)
- Investors on record: 4

## About

Based in the US, SwishX is a technology firm that provides an AI-native Commercial Excellence Platform for the pharmaceutical and MedTech sectors, enhancing operational efficiency through advanced analytics and real-time insights.Founded in 2026 in Los Altos, US, SwishX specializes in delivering a Commercial Excellence Platform designed to optimize operations for pharmaceutical and life sciences companies. The company raised USD 2.2 mn in Seed funding on May 12, 2026, from investors including Atrium Ventures, Blume Ventures, Powerhouse Ventures, and Sadev Ventures. SwishX has completed a total of 1 deal to date.SwishX offers an advanced AI-native Commercial Excellence Platform tailored specifically for the pharmaceutical and MedTech industries. The platform encompasses four key products: Marketing IQ, Tender IQ, Channel IQ, and Contract IQ. These products work collaboratively to enhance commercial operations by providing real-time visibility, insights, and actionable recommendations across the entire distribution network. For instance, Marketing IQ connects healthcare professional (HCP) touchpoints to verified prescription outcomes, while Tender IQ automates the discovery and submission of tenders, enabling companies to identify opportunities swiftly. Targeted at commercial teams in the pharmaceutical and life sciences sectors, SwishX serves a global clientele, with deployments reported in over 25 countries, including major markets such as the USA, India, the UK, and Singapore. The platform’s functionality is designed to address key challenges in revenue generation and compliance, effectively streamlining operations for companies of various sizes.The revenue structure of SwishX is driven by a SaaS-based model, where clients subscribe to its suite of products for a designated period. Transactions typically occur through annual or multi-year subscription agreements, allowing firms to leverage the platform’s capabilities continuously. The client base primarily consists of large pharmaceutical enterprises and MedTech companies, which engage with SwishX to optimize their commercial strategies and enhance operational efficiency. Each product, particularly the flagship offerings like Tender IQ and Contract IQ, plays a significant role in driving revenue by automating tedious processes and ensuring compliance, thereby reducing operational costs for clients. Given the focus on compliance and efficiency, the pricing may vary based on the scale and specific needs of the client, aligning with the complexity and volume of the services utilized, but precise pricing details are tailored to individual contracts.In May 2026, SwishX raised USD 2.2 mn in Seed funding, which will be utilized to launch its platform and support expansion into new markets and customer acquisition. The company aims to enhance its product offerings further and explore opportunities in additional regions, although specific target markets and timelines have not been disclosed.

## Funding rounds

- Seed, May 12, 2026, $2.2M — Blume Ventures, Atrium Ventures, Powerhouse Ventures, Sadev Ventures

## Investors

- Blume Ventures (https://capitalatlas.ai/funds/blume-ventures) — Seed
- Atrium Ventures (https://capitalatlas.ai/funds/atrium-ventures) — Seed
- Powerhouse Ventures — Seed
- Sadev Ventures (https://capitalatlas.ai/funds/sadev-ventures) — Seed